Marc Stapley

Director

Marc Stapley (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $6.9M of VCYT (138,051 sh × $50.12, as filed), executed Jun 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$10.8M

shares × price, as filed

Last traded

Jun 4

Filed Jun 4

Median ADV $55.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $13.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

VCYT

Veracyte, Inc. VCYT · 0 buys · 6 sells 6 filings GKOS

Glaukos Corporation GKOS · 0 buys · 1 sell 1 filing

Recent filings

VCYTSALE Veracyte, Inc. View filing → $6.9M
138,051 sh × $50.12
Exec Jun 4
Filed Jun 4 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $1.6M
45,523 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $1.9M
15,000 sh across 5 lots
Exec Jan 22
Filed Jan 26 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $361K
7,668 sh across 2 lots
Exec Dec 4 2025
Filed Dec 4 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $233K
7,667 sh × $30.41
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $1.7M
51,603 sh across 2 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $225K
5,190 sh × $43.37
Exec Dec 13 2024
Filed Dec 17 2024 · 5:30 PM ET